Target intelligence / Profile preview

Solute carrier family 2 facilitated glucose transporter member 8 (SLC2A8)

Target
SLC2A8
Molecular classification
Transporter, Solute carrier family (SLC), Facilitated glucose transporter
01

Overview

Solute carrier family 2 facilitated glucose transporter member 8 (SLC2A8, also known as GLUT8) is a membrane transporter protein belonging to the solute carrier family 2. It features 12 transmembrane domains and is primarily involved in the facilitated, insulin-regulated transport of glucose and fructose, as well as other hexoses such as trehalose and dehydroascorbate. SLC2A8 is highly expressed in certain tissues including liver and is essential for hepatic uptake of trehalose, which in turn can trigger autophagy through AMPK-ULK1 signaling. The transporter’s function has been implicated in metabolic processes relevant to liver health, energy regulation, and possibly in some disease states such as hepatic steatosis and neurodegeneration through its role in autophagic signaling. It is a functionally validated transporter target for investigative drugs and metabolic interventions, with trehalose itself being a key molecule for experimental modulation of SLC2A8 activity[1][2][3].

Other names
GLUT8GLUTX1GLUT-8Glucose transporter type 8Glucose transporter type X1solute carrier family 2 member 8
02

Mechanism of action

Competitive substrate inhibition (trehalose inhibits glucose and fructose influx by competing at the transporter binding site); Modulation of AMPK signaling pathway leading to autophagy induction (via trehalose transport and cellular energy sensing)

03

Biological functions

Transmembrane glucose transportTransmembrane fructose transportHepatic trehalose influxRegulation of cellular energy homeostasisRegulation of hepatic autophagy
04

Disease associations

Metabolic disordersHypoascorbemiaArterial tortuosity syndromeNon-alcoholic fatty liver disease (experimental)Neurodegenerative disease (experimental)
05

Safety considerations

Off-target metabolic effects due to broad tissue expression of GLUT transportersPotential disturbances in glucose/hexose homeostasis if inhibited systemically
06

Interacting drugs

Trehalose
07

Biomarkers

LC3B-II (autophagic marker, in trehalose-induced hepatic studies)

Beyond the preview

Go deeper on Solute carrier family 2 facilitated glucose transporter member 8 (SLC2A8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 2 facilitated glucose transporter member 8 (SLC2A8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call